Abstract

BackgroundThe result of post-marketing surveillance (PMS) of 3985 patients reported previously1 indicated that prior use of biologics, with or without concomitant methotrexate (MTX), was associated with the safety and effectiveness...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call